Clinical Data to Offer 3M Shares; Cash Will Fund Acquisitions, Other Expenses | GenomeWeb

Clinical Data to Offer 3M Shares; Cash Will Fund Acquisitions, Other Expenses

Jul 10, 2007

NEW YORK (GenomeWeb News) — Clinical Data plans to offer 3 million shares of its common stock through an underwritten public offering, the company said yesterday.

Clinical Data will use the proceeds from the offering to fund clinical trials, preclinical R&D for corporate purposes such as acquisitions, capital expenses, and working capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.